In glioblastoma (C6) cells, garcinol treatment reduced NF-κB expression and downstream gene products associated with cell survival and proliferation, including Bcl-2, Bcl-xL, survivin, and cyclin D1 [44] and PDGFR [45]. This evidence concerns the gene BCL2L1 and glioblastoma.